1 |
Delwarde C, Capoulade R, Mérot J, Le Scouarnec S, Bouatia-Naji N, Yu M, Huttin O, Selton-Suty C, Sellal JM, Piriou N, Schott JJ, Dina C, Le Tourneau T. Genetics and pathophysiology of mitral valve prolapse. Front Cardiovasc Med 2023;10:1077788. [PMID: 36873395 DOI: 10.3389/fcvm.2023.1077788] [Reference Citation Analysis]
|
2 |
Ghilardi S, Lecchi C, Bagardi M, Romito G, Colombo FM, Polli M, Franco C, Brambilla PG. Prospective pilot study on the predictive significance of plasma miR-30b-5p through the study of echocardiographic modifications in Cavalier King Charles Spaniels affected by different stages of myxomatous mitral valve disease: The PRIME study. PLoS One 2022;17:e0274724. [PMID: 36574372 DOI: 10.1371/journal.pone.0274724] [Reference Citation Analysis]
|
3 |
Ghilardi S, Lecchi C, Bagardi M, Romito G, Colombo FM, Polli M, Franco C, Brambilla PG. Preliminary prospective study on the predictive significance of plasma miR-30b-5p through the study of echocardiographic modifications in Cavalier King Charles Spaniels affected by different stages of myxomatous mitral valve disease: the PRIME study.. [DOI: 10.1101/2022.09.05.506710] [Reference Citation Analysis]
|